High-throughput screening, traditionally the domain of big ... “We're looking at drug-proteome interactions,” says Gitte Neubauer, vice president of research operations at Cellzome, who ...
The AI in Drug Discovery Market is experiencing substantial expansion, boosted by AI-powered innovations in drug optimization, repurposing, and preclinical testing.Pune, Jan. 13, 2025 (GLOBE NEWSWIRE) ...
PhenoVista Biosciences, a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services bas ...